| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |